Another study found significant differences between groups of patients with type I SMA and controls and between patients with types I–III SMA and control groups in terms of the levels of FL-SMN and Δ7-SMN mRNAs [145]. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.